Abiomed Third Quarter Fiscal 2015 Earnings and Conference Call Notification
January 06 2015 - 8:00AM
Abiomed, Inc. (Nasdaq:ABMD) announced today that on Tuesday,
January 27, 2015, the Company will release financial results for
the third quarter of fiscal 2015. The Company will host a
conference call to discuss the results on Tuesday, January 27,
2015, at 8:00 a.m. EST. Michael R. Minogue, Chairman, President and
Chief Executive Officer; Robert L. Bowen, Vice President and Chief
Financial Officer, will host the conference call.
To listen to the call live, please tune into the webcast via
http://investor.abiomed.com or dial (855) 212-2361; the
international number is (678) 809-1538. A replay of this conference
call will be available beginning at 11 a.m. EST January 27, 2015
through 11:59 p.m. EST on February 3, 2015. The replay phone number
is (855) 859-2056; the international number is (404) 537-3406. The
replay access code is 5150221.
ABOUT ABIOMED
Based in Danvers, Massachusetts, Abiomed, Inc., is a leading
provider of medical devices that provide circulatory support. Our
products are designed to enable the heart to rest by improving
blood flow and/or performing the pumping of the heart. For
additional information please visit: www.abiomed.com
FORWARD-LOOKING STATEMENTS
This release contains forward-looking statements, including
statements regarding development of Abiomed's existing and new
products, the Company's progress toward commercial growth, and
future opportunities and expected regulatory approvals. The
Company's actual results may differ materially from those
anticipated in these forward-looking statements based upon a number
of factors, including uncertainties associated with development,
testing and related regulatory approvals, including the potential
for future losses, complex manufacturing, high quality
requirements, dependence on limited sources of supply, competition,
technological change, government regulation, litigation matters,
future capital needs and uncertainty of additional financing, and
other risks and challenges detailed in the Company's filings with
the Securities and Exchange Commission, including the most recently
filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q.
Readers are cautioned not to place undue reliance on any
forward-looking statements, which speak only as of the date of this
release. The Company undertakes no obligation to publicly release
the results of any revisions to these forward-looking statements
that may be made to reflect events or circumstances that occur
after the date of this release or to reflect the occurrence of
unanticipated events.
CONTACT: Ingrid Goldberg
Director, Investor Relations
978-646-1590
igoldberg@abiomed.com
ABIOMED (NASDAQ:ABMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
ABIOMED (NASDAQ:ABMD)
Historical Stock Chart
From Apr 2023 to Apr 2024